Semarion

Provider of a platform for drug discovery and screening

placeCambridge, England, United Kingdom calendar_todayFounded 2018 groups3 employees language semarion.com

Registered entities

Social engagement

Social engagement: 1.9K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Parkwalk.

Investor typeCountShare
Venture capital220%
Private equity110%
Angel & family office110%
Accelerator & incubator110%
Other / undisclosed550%

Recent activity

11 Mar 2026
Event
Reimagining adherent cell assays through the combination of SemaCyte microcarrier and firefly automation platforms
23 Dec 2025
Milestone
anniversary
Coming soon